These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9493152)

  • 41. FDG-PET in healthy and epileptic Lagotto Romagnolo dogs and changes in brain glucose uptake with age.
    Jokinen TS; Haaparanta-Solin M; Viitmaa R; Grönroos TJ; Johansson J; Bergamasco L; Snellman M; Metsähonkala L
    Vet Radiol Ultrasound; 2014; 55(3):331-41. PubMed ID: 24354474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus.
    Kasitanon N; Louthrenoo W; Piyasirisilp S; Sukitawu W; Wichainun R
    Asian Pac J Allergy Immunol; 2002 Sep; 20(3):179-85. PubMed ID: 12587842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coincident systemic lupus erythematosus and psoriasis vulgaris: a case report.
    Wang Y; Da G; Yu Y; Han J; Li H
    G Ital Dermatol Venereol; 2015 Dec; 150(6):749-51. PubMed ID: 25058036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effective treatment of a refractory case of systemic lupus erythematosus with low-dose tacrolimus].
    Oki E; Tsugawa K; Suzuki K; Tanaka H
    Nihon Jinzo Gakkai Shi; 2007; 49(8):1020-4. PubMed ID: 18186231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic value of [F]FDG-PET in nonrefractory partial epilepsy.
    Weitemeyer L; Kellinghaus C; Weckesser M; Matheja P; Loddenkemper T; Schuierer G; Schober O; Ringelstein EB; Lüdemann P
    Epilepsia; 2005 Oct; 46(10):1654-60. PubMed ID: 16190939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic lupus erythematosus complicated with cerebral venous sinus thrombosis : a report of two cases.
    Lee MK; Kim JH; Kang HR; Rho HJ; Nam EJ; Kim SW; Kang YM; Lee JM; Kim NS
    J Korean Med Sci; 2001 Jun; 16(3):351-4. PubMed ID: 11410699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful treatment of cerebral large vessel vasculitis in systemic lupus erythematosus with intravenous pulse cyclophosphamide.
    Kato R; Sumitomo S; Kawahata K; Fujio K; Yamamoto K
    Lupus; 2015 Jul; 24(8):880-4. PubMed ID: 25661835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging.
    Zimny A; Szmyrka-Kaczmarek M; Szewczyk P; Bladowska J; Pokryszko-Dragan A; Gruszka E; Wiland P; Sasiadek M
    Lupus; 2014; 23(1):10-9. PubMed ID: 24192079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
    Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.
    Sabbadini MG; Manfredi AA; Bozzolo E; Ferrario L; Rugarli C; Scorza R; Origgi L; Vanoli M; Gambini O; Vanzulli L; Croce D; Campana A; Messa C; Fazio F; Tincani A; Anzola G; Cattaneo R; Padovani A; Gasparotti R; Gerli R; Quartesan R; Piccirilli M; Farsi A; Emmi E; Passaleva A
    Lupus; 1999; 8(1):11-9. PubMed ID: 10025594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients.
    Saison J; Costedoat-Chalumeau N; Maucort-Boulch D; Iwaz J; Marignier R; Cacoub P; Vital-Durand D; Hot A; Tebib J; Aumaitre O; Schleinitz N; Sarrot-Reynauld F; Broussolle C; Sève P
    Lupus; 2015 Jan; 24(1):74-81. PubMed ID: 25117654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversible parkinsonism in systemic lupus erythematosus.
    Tan EK; Chan LL; Auchus AP
    J Neurol Sci; 2001 Dec; 193(1):53-7. PubMed ID: 11718751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fulminant lupus pneumonitis with acute renal failure and RBC aplasia. Successful management with plasmapheresis and immunosuppression.
    Isbister JP; Ralston M; Hayes JM; Wright R
    Arch Intern Med; 1981 Jul; 141(8):1081-3. PubMed ID: 7247596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective suppression of resting B cell function in patients with systemic lupus erythematosus treated with cyclophosphamide.
    Takeno M; Suzuki N; Nagafuchi H; Mizushima Y; Sakane T
    Clin Exp Rheumatol; 1993; 11(3):263-70. PubMed ID: 8353980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Gang W; Li PK
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.